Use of misoprostol during pregnancy and Mobius' syndrome in infants

New England Journal of Medicine

Volumn 338, Issue 26 I, 1998, Pages 1881-1885

  Pastuszak, Anne L ^a,i   Schüler, Lavinia ^b,c   Speck Martins, Carlos E ^d   Coelho, Katia Edni F A ^e   Cordello, Synthia M ^e   Vargas, Fernando ^f   Brunoni, Decio ^g,h   Schwarz, Ida V D ^c   Larrandaburu, Mariela ^c   Safattle, Heloisa ^d   Meloni, Vera F A ^g,h   Koren, Gideon ^a   Neto, Jordão C ^g,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d Rede de Hospitais Sarah   (Brazil)

^e Rede de Hospitais Sarah   (Brazil)

^f HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; ABORTIVE AGENT; TERATOGENIC AGENT;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFECT; FEMALE; HUMAN; INFANT; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MOEBIUS SYNDROME; NEURAL TUBE DEFECT; ORAL DRUG ADMINISTRATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FACIAL NERVE PARALYSIS; FIRST TRIMESTER PREGNANCY; INDUCED ABORTION; METHODOLOGY; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; RISK;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; CASE-CONTROL STUDIES; FACIAL PARALYSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MISOPROSTOL; NEURAL TUBE DEFECTS; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; TERATOGENS;

EID: 2642599038     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199806253382604     Document Type: Article

References (23)

1. Baird DT, Norman JE, Thong KJ, Glasier AF. Misoprostol, mifepristone, and abortion. Lancet 1992;339:313.
2. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnacy. N Engl J Med 1995;333:537-40.
3. Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993;341:1258-61. [Erratum, Lancet 1993;341:1486.]
4. Coelho HLL, Teixeira AC, Santos AP, et al. Misoprostol and illegal abortion in Fortaleza, Brazil. Lancet 1993;341:1261-3.
5. Fonseca W, Misago C, Corrcia LL, Parente JAM, Oliveira FC. Determinantes do aborto provocado entre mulheres admitidas em hospitais em localide da região Nordeste do Brasil. Rev Saude Publica 1996;30:13-8.
6. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-6.
7. Esaki K, Sasa H, Umemura T, et al. Effect of intragastric administration of misoprostol dispersion on reproduction in rats. II. Experiment on drug administration in the pre-and early gestation periods. Jitchuken Zenrinsho Kenkyuho 1985;11:167-87.
8. Idem. Effect of intragastric administration of misoprostol (SC-29333) dispersion on reproduction in rats. III. Experiment on drug administration during the organogenesis period. Jitchuken Zenrinsho Kenkyuho 1985;11:189-211.
9. Idem. Effect of intragastric administration of misoprostol (SC-29333) dispersion on reproduction in rats. IV. Experiment on drug administration during the peripartum and nursing periods. Jitchuken Zenrinsho Kenkyuho 1985;11:213-27.
10. Paumgartten FJ, Magalhaes-de-Souza CA, de Carvalho RR, Chahoud I. Embryotoxic effects of misoprostol in the mouse. Braz J Med Biol Res 1995;28:355-61.
11. Bond GR, Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 1994;171:561-2.
12. Gonzalez CH, Vargas FR, Perez ABA, et al. Limb deficiency with or without Möbius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64.
13. Genest DR, Richardson A, Rosenblatt M, Holmes L. Limb defects and omphalocele in a 17 week fetus following first trimester misoprostol exposure. Teratology 1994;49:418. abstract.
14. Castilla EE, Orioli IM. Teratogenicity of misoprostol: data from the Latin-American Collaborative Study of Congenital Malformations. Am J Med Genet 1994;51:161-2.
15. Schüler L, Ashton PW, Sanseverino MT. Teratogenicity of misoprostol. Lancet 1992;339:437.
16. Kumar D. Moebius syndrome. J Med Genet 1990;27:122-6.
17. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
18. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-3.
19. Lipson AH, Webster WS, Brown-Woodman PDC, Osborn RA. Moebius syndrome: animal model - human correlations and evidence for a brainstem vascular etiology. Teratology 1989;40:339-50.
20. Holmes LB. Possible fetal effects of cervical dilation and uterine curettage during the first trimester of pregnancy. J Pediatr 1995;126:131-4.
21. Shepard TH. Möbius syndrome after misoprostol: a possible teratogenic mechanism. Lancet 1995;346:780.
22. Lipson AH, Gillerot Y, Tannenberg AEG, Giurgea S. Two cases of maternal antenatal splenic rupture and hypotension associated with Moebius syndrome and cerebral palsy in offspring: further evidence for a utero placental vascular aetiology for the Moebius syndrome and some cases of cerebral palsy. Eur J Pediatr 1996;155:800-4.
23. Schüler L, Pastuszak A, Sanseverino MT, Orioli IM, Brunoni D, Koren G. Pregnancy outcome after abortion attempt with misoprostol. Teratology 1997;55:36. abstract.